ARCHIVES

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Approves Concept Of Converting Baltimore Program To Cancer Center; New DCCP Labs Named

June 5, 1981

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Consensus Panel Determines Total Mastectomy Plus Node Dissection “Satisfactory Alternative” To Radical Mastectomy

June 15, 1979

In Brief: NCI Anniversary Party Moved To May 26; Patricia Randall Heads Women Radiologists

February 27, 1987

NCI Sets its Targets for Grant Success Rate and R01 Payline for FY05.

January 21, 2005